Edwards CJ - Search Results

1

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ. Westlake SL, et al. Among authors: edwards cj. Rheumatology (Oxford). 2011 Mar;50(3):518-31. doi: 10.1093/rheumatology/keq316. Epub 2010 Nov 11. Rheumatology (Oxford). 2011. PMID: 21071477 Review.

2

The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.

Edwards CJ, Arden NK, Fisher D, Saperia JC, Reading I, Van Staa TP, Cooper C. Edwards CJ, et al. Rheumatology (Oxford). 2005 Nov;44(11):1394-8. doi: 10.1093/rheumatology/kei024. Epub 2005 Jul 19. Rheumatology (Oxford). 2005. PMID: 16030083

3

Growth and infectious exposure during infancy and the risk of rheumatoid factor in adult life.

Edwards CJ, Goswami R, Goswami P, Syddall H, Dennison EM, Arden NK, Cooper C. Edwards CJ, et al. Ann Rheum Dis. 2006 Mar;65(3):401-4. doi: 10.1136/ard.2005.036301. Epub 2005 Aug 3. Ann Rheum Dis. 2006. PMID: 16079171 Free PMC article.

4

Immunological therapies for rheumatoid arthritis.

Edwards CJ. Edwards CJ. Br Med Bull. 2005 Sep 20;73-74:71-82. doi: 10.1093/bmb/ldh051. Print 2005. Br Med Bull. 2005. PMID: 16174791 Review.

5

Pulmonary nodular amyloidosis and systemic lupus erythematosus.

Westlake S, Edwards CJ. Westlake S, et al. Among authors: edwards cj. Lupus. 2005;14(8):639-40. doi: 10.1191/0961203305lu2161xx. Lupus. 2005. PMID: 16175939 No abstract available.

6

Early environmental factors and rheumatoid arthritis.

Edwards CJ, Cooper C. Edwards CJ, et al. Clin Exp Immunol. 2006 Jan;143(1):1-5. doi: 10.1111/j.1365-2249.2005.02940.x. Clin Exp Immunol. 2006. PMID: 16367927 Free PMC article. Review.

7

The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men.

Edwards CJ, Syddall H, Goswami R, Goswami P, Dennison EM, Arden NK, Cooper C; Hertfordshire Cohort Study Group. Edwards CJ, et al. Heart. 2007 Oct;93(10):1263-7. doi: 10.1136/hrt.2006.097816. Epub 2007 Jun 5. Heart. 2007. PMID: 17550930 Free PMC article.

8

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.

Edwards CJ, Cooper C, Fisher D, Field M, van Staa TP, Arden NK. Edwards CJ, et al. Arthritis Rheum. 2007 Oct 15;57(7):1151-7. doi: 10.1002/art.23003. Arthritis Rheum. 2007. PMID: 17907232 Free article.

9

Anti-malarials and Lupus in West Africa use and lupus in Africans.

Westlake SL, Edwards CJ. Westlake SL, et al. Among authors: edwards cj. Lupus. 2009 Mar;18(3):193-5. doi: 10.1177/0961203308098383. Lupus. 2009. PMID: 19213855 No abstract available.

10

The BILAG-2004 index is sensitive to change for assessment of SLE disease activity.

Yee CS, Farewell V, Isenberg DA, Griffiths B, Teh LS, Bruce IN, Ahmad Y, Rahman A, Prabu A, Akil M, McHugh N, Edwards C, D'Cruz D, Khamashta MA, Maddison P, Gordon C. Yee CS, et al. Rheumatology (Oxford). 2009 Jun;48(6):691-5. doi: 10.1093/rheumatology/kep064. Epub 2009 Apr 24. Rheumatology (Oxford). 2009. PMID: 19395542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page